Ceftriaxone & Sulbactam For Inj. 375mg/750mg/1.5gm

What is Ceftriaxone & Sulbactam For Inj. 375mg/750mg/1.5gm?

Ceftriaxone & Sulbactam For Inj. is a combination antibacterial product presented as a dry powder injection. Ceftriaxone is a cephalosporin antibiotic, while sulbactam is a beta-lactamase inhibitor. The combination may be used for selected bacterial infections when clinically appropriate. Its indications, dosage and administration must follow the approved product information.

Ceftriaxone and sulbactam are combined to provide antibacterial activity against certain susceptible bacteria, including selected organisms that produce beta-lactamases.

Potential clinical applications depend on the approved indications for the specific formulation and local prescribing guidelines. The combination may be considered for selected bacterial infections involving susceptible organisms.

• Treatment decisions should consider the infection site and severity.

• Bacterial culture and susceptibility results should guide treatment where available.

• The product should not be used for viral infections such as influenza or the common cold.

The approved indications for this specific combination should be confirmed from its authorised prescribing information.

5. Benefits

• Combines ceftriaxone, a cephalosporin antibiotic, with sulbactam, a beta-lactamase inhibitor.

• Available as a dry powder injection presentation.

• Offered in the listed strengths of 375mg, 750mg and 1.5gm, subject to confirmation of the exact formulation and strength labelling.

• Intended for use in appropriate clinical settings under professional supervision.

• Pharmaceutical sourcing and export enquiries can be directed to Kelar Pharmachem India, subject to availability and confirmation.

6. Side Effects

Common Side Effects

Potential adverse effects associated with ceftriaxone-containing products include:

• Diarrhoea or loose stools.

• Nausea or vomiting.

• Skin rash or itching.

• Injection-site pain or tenderness.

• Changes in liver enzyme results.

Less Common or Serious Side Effects

• Severe allergic reactions, including anaphylaxis.

• Severe or persistent antibiotic-associated diarrhoea.

• Changes in blood cell counts.

• Biliary complications associated with ceftriaxone.

• Kidney-related complications in susceptible patients.

• Serious skin reactions.

The side-effect profile of this particular combination should be verified against its approved product information. Seek urgent medical attention for breathing difficulties, facial or throat swelling, severe skin reactions or other signs of a serious adverse reaction.

7. How Does It Work?

Ceftriaxone works by inhibiting bacterial cell-wall synthesis, leading to the death of susceptible bacteria. Sulbactam inhibits certain beta-lactamase enzymes produced by bacteria, which can otherwise break down some beta-lactam antibiotics. This may help protect the antibiotic against susceptible beta-lactamase enzymes. The combination does not work against all bacteria, and its effectiveness depends on the organism and its susceptibility.

8. Dosage Guidelines

The dose and duration depend on the infection, its severity, the patient’s age and weight, kidney and liver function where relevant, and the approved product information.

• Use only under the direction of a qualified healthcare professional.

• Confirm the exact composition and strength of the combination before prescribing or administration.

• Follow the product-specific instructions for reconstitution, diluent selection and administration route.

• Consider relevant renal or hepatic impairment and other patient-specific factors.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

9. When Not to Use

The combination should not be used in patients with a known contraindication to the product or a relevant history of serious hypersensitivity to its ingredients.

• Inform the healthcare professional about previous reactions to ceftriaxone, sulbactam, cephalosporins, penicillins or other beta-lactam antibiotics.

• Specific restrictions apply to ceftriaxone use in certain neonates, including relevant hyperbilirubinaemia risks and intravenous calcium-containing solutions.

• Other contraindications must be checked against the approved information for this particular formulation.

A healthcare professional should assess the patient’s medical history and allergy risks before treatment.

10. Drug / Product Interactions

Potential interactions and precautions depend on the exact formulation and the patient’s other medicines.

• Calcium-containing intravenous solutions: Ceftriaxone has specific restrictions for certain neonatal patients. Follow the approved compatibility and administration instructions.

• Anticoagulants: Monitoring may be appropriate in selected patients.

• Other antibiotics: Concurrent use should be based on a clear clinical indication.

• Medicines affecting kidney function: Review the full medication regimen where renal risks are relevant.

Do not mix this combination with other medicines in the same syringe or infusion line unless compatibility is confirmed by authoritative product-specific information.

11. Safety Advice

• Use only under appropriate medical supervision.

• Check the patient’s allergy history before administration.

• Verify the prescribed dose, strength and route.

• Follow the approved preparation and administration instructions.

• Monitor for significant allergic reactions and other clinically important adverse effects.

• Use antibiotics only for appropriate bacterial indications to help reduce antimicrobial resistance.

• Inform the healthcare professional about pregnancy, breastfeeding, neonatal status and significant kidney or liver conditions.

12. General Instructions

• Verify the product name, strength, batch number and expiry date before use.

• Inspect the vial and container closure for damage.

• Maintain appropriate aseptic handling practices.

• Follow the approved product-specific reconstitution and administration instructions.

• Do not use a damaged or compromised container.

• Follow the approved instructions for handling and use after reconstitution.

• Dispose of unused medicine and clinical waste according to applicable procedures.

Do not assume that diluent volumes, compatibility or post-reconstitution stability are the same for every ceftriaxone and sulbactam presentation.

13. Special Dietary / Lifestyle Tips

No universal dietary restriction applies to all presentations of this injectable combination.

• Follow the treatment plan provided by the healthcare professional.

• Complete the prescribed course as directed.

• Report persistent diarrhoea or unexpected symptoms.

• Do not share antibiotics or use leftover medicines for another illness.

14. Comparison with Other Treatments

The combination is not automatically more appropriate than other antibiotics in every clinical situation. Treatment selection should consider the causative organism, susceptibility results, infection site, patient factors and applicable treatment guidelines.

15. Precautions & Warnings

• Hypersensitivity: Assess previous reactions to cephalosporins and other beta-lactam antibiotics.

• Neonatal use: Follow the specific restrictions applicable to ceftriaxone-containing products.

• Gastrointestinal effects: Severe or persistent diarrhoea requires medical evaluation.

• Renal and hepatic conditions: Assess whether monitoring or treatment adjustments are needed.

• Pregnancy and breastfeeding: Use only after an appropriate clinical assessment.

• Antimicrobial resistance: Avoid unnecessary antibiotic use and follow appropriate prescribing guidelines.

• Formulation verification: Confirm the exact ceftriaxone-to-sulbactam ratio for the listed strengths before publication or clinical use.

16. Can I Use It With Other Medicines?

Use with other medicines depends on the combination’s approved prescribing information, the other medicines involved and the patient’s clinical condition.

Inform the healthcare professional about all prescription medicines, non-prescription products and supplements being used. Additional monitoring or precautions may be needed with selected medicines.

Physical compatibility when mixing medicines is different from an interaction after administration. Do not combine products in a syringe or infusion line without confirmed compatibility.

17. Storage

Store according to the manufacturer’s approved product labelling. Refer to the product packaging or package insert for the applicable storage conditions.

Follow the product-specific instructions for unopened vials and for the solution after reconstitution. Do not assume a universal storage temperature or post-reconstitution shelf life.

18. Frequently Asked Questions (FAQs)

1. What is Ceftriaxone & Sulbactam For Inj. used for?

It is a combination antibacterial product intended for selected bacterial infections when supported by the approved prescribing information and clinical assessment.

2. Which active ingredients does this product contain?

The listed ingredients are ceftriaxone and sulbactam.

3. Which strengths are listed?

The supplied product name lists 375mg, 750mg and 1.5gm. The exact composition and strength labelling of each presentation should be confirmed with the supplier.

4. How is this dry powder injection prepared?

A qualified healthcare professional must prepare it according to the approved product-specific instructions, including the correct diluent and administration method.

5. Can patients with a penicillin allergy use this combination?

A history of penicillin allergy requires individual clinical assessment. The risk depends on the patient’s previous reaction and the specific medicine.

6. What precautions apply to this combination?

Important considerations include allergy history, patient-specific risk factors, ceftriaxone-related neonatal restrictions and the approved administration instructions.

7. How should this product be stored?

Follow the manufacturer’s approved labelling and package insert for storage conditions and handling after reconstitution.

8. Is this product available for pharmaceutical export?

Kelar Pharmachem India accepts pharmaceutical sourcing and export enquiries. Availability, exact formulation, destination-market requirements and supporting documentation must be confirmed individually.